CS logo
small CS logo
Alegent Health Mercy Hospital

Council Bluffs, Iowa, United States
Hospital in Council Bluffs, Iowa
800 Mercy Dr, Council Bluffs, IA 51503

About Alegent Health Mercy Hospital


"Visitation restrictions are currently in place to decrease possible exposure to Coronavirus (COVID-19). Please visit our website for more information. CHI Health Mercy Council Bluffs is dedicated to delivering high quality, compassionate care to Council Bluffs and nearby communities. Visit us at 800 Mercy Dr or call (712) 328-5000 for more information."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
77
SWOG Cancer Research Network
31
Alliance for Clinical Trials in Oncology
26
ECOG-ACRIN Cancer Research Group
16
NRG Oncology
5
Wake Forest University Health Sciences
3
Children's Oncology Group
2
Gynecologic Oncology Group
2
Eastern Cooperative Oncology Group
1
Radiation Therapy Oncology Group
1
Total Rows: 10

Clinical Trials at Alegent Health Mercy Hospital


During the past decade, Alegent Health Mercy Hospital conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 49 clinical trials were completed, i.e. on average, 44.5% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 38 clinical trials were completed. i.e. 126.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years15159916161818222220201010111111226611111212Started TrialsCompleted Trails20152016201720182019202020210102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
2002-12-01
Completed
171
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
2002-10-01
2008-10-01
Completed
67
Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer
2002-11-01
2010-01-01
Completed
71
Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
2003-06-01
2019-09-01
Completed
64
Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer
2003-03-01
2008-05-01
Completed
216
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732

Rows per page:

1–100 of 164

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Alegent Health Mercy Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 77 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alegent Health Mercy Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 86 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 23 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Alegent Health Mercy Hospital


According to Clinical.Site data, the most researched conditions in "Alegent Health Mercy Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Alegent Health Mercy Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Alegent Health Mercy Hospital


Most popular intervention types in "Alegent Health Mercy Hospital" are "Drug" (130 trials), "Other" (98 trials), "Biological" (74 trials), "Procedure" (43 trials) and "Radiation" (12 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (38 trials), "Computed Tomography" (25 trials), "Nivolumab" (25 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

Clinical Trials Genders at Alegent Health Mercy Hospital


The vast majority of trials in "Alegent Health Mercy Hospital" are 131 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.

Clinical Trials Status at Alegent Health Mercy Hospital


Currently, there are NaN active trials in "Alegent Health Mercy Hospital". undefined are not yet recruiting, 52 are recruiting, 74 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Alegent Health Mercy Hospital, 1 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Alegent Health Mercy Hospital, 4 "Phase 1" clinical trials were conducted, 79 "Phase 2" clinical trials and 82 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status